Results 31 to 40 of about 881 (146)

Circulating Cell-free DNA Fragmentomics Detection and Beyond

open access: yesaging and disease
Circulating cell-free DNA (cfDNA) comprises DNA fragments released into bodily fluids via apoptosis, necrosis, or phagocytosis. cfDNA encapsulates both fragmentomics (structural) and non-fragmentomics (sequence/epigenetic) information from source cells, thereby representing a promising biomarker.
Tianliang, Liu   +3 more
exaly   +3 more sources

Multidimensional roles of cfDNA fragmentomics in preeclampsia: from placental hypoxia and TLR9 inflammation to clinical risk stratification [PDF]

open access: yesFrontiers in Medicine
Cell-free DNA (cfDNA) has emerged as a pivotal biomarker for predicting preeclampsia (PE), a multisystem syndrome characterized by placental hypoperfusion and systemic inflammation.
Ziyi Guo, Bin Zhang, Di Yang, Li Wang
doaj   +2 more sources

Cell-free DNA fragmentomics for preeclampsia risk assessment

open access: yesNature Communications
Preeclampsia (PE) is a pregnancy-specific hypertensive disorder that could lead to serious maternal and fetal complications, yet early identification of women at risk remains challenging because reliable biomarkers are limited.
Wenqiu Xu   +39 more
doaj   +2 more sources

Comprehensive fragmentation of cell-free repetitive DNA for enhanced cancer detection in plasma [PDF]

open access: yesFrontiers in Cell and Developmental Biology
BackgroundRepetitive elements account for a large proportion of the human genome and undergo alterations during early tumorigenesis. However, the exclusive fragmentation pattern of DNA-derived cell-free repetitive elements (cfREs) remains unclear ...
Mingguang Zhang   +7 more
doaj   +2 more sources

Fragmentomic liquid biopsy enables early breast cancer detection, molecular subtyping and lymph node assessment [PDF]

open access: yesNature Communications
Breast cancer remains a leading global health concern in women, while screening is still limited by imaging accessibility and reduced sensitivity in dense breasts.
Yuxuan Zhu   +26 more
doaj   +2 more sources

Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.

open access: yesPLoS Genetics, 2022
Urinary cell-free DNA (ucfDNA) is a potential biomarker for bladder cancer detection. However, the biological characteristics of ucfDNA are not well understood.
Meihui Chen   +18 more
doaj   +3 more sources

GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing [PDF]

open access: yesMolecular Cancer
Background Gastrointestinal (GI) cancers are among the most prevalent and lethal malignancies worldwide. Early, non-invasive detection is essential for timely intervention and improved survival.
Ao Huang   +28 more
doaj   +2 more sources

DeepFRAG: a method for cancer detection based on DNA fragmentomics and deep learning. [PDF]

open access: yesBioinform Adv
Abstract Motivation Cancer screening using liquid biopsy technology has become standard in modern clinical and preventive oncology. This method analyzes cell-free DNA (cfDNA) circulating in a patient’s bloodstream.
Koch A, Giladi E.
europepmc   +4 more sources

Fragmentomics features of cell free DNA in eating disorders

open access: yesTranslational Psychiatry
Eating disorders are lacking reliable biomarkers despite their severe psychiatric and medical burden. In this study, we examined plasma cell-free DNA (cfDNA) from patients with the restrictive (ANR), or binge–purge (ANBP) subtypes of anorexia nervosa, as
Alisa Burova   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy